1,259
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 213-225 | Received 11 Dec 2023, Accepted 23 Jan 2024, Published online: 08 Feb 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.